Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

703 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A single-point modeling approach for the intercomparison and evaluation of ozone dry deposition across chemical transport models (Activity 2 of AQMEII4).
Clifton OE, Schwede D, Hogrefe C, Bash JO, Bland S, Cheung P, Coyle M, Emberson L, Flemming J, Fredj E, Galmarini S, Ganzeveld L, Gazetas O, Goded I, Holmes CD, Horváth L, Huijnen V, Li Q, Makar PA, Mammarella I, Manca G, Munger JW, Pérez-Camanyo JL, Pleim J, Ran L, Jose RS, Silva SJ, Staebler R, Sun S, Tai APK, Tas E, Vesala T, Weidinger T, Wu Z, Zhang L. Clifton OE, et al. Among authors: horvath l. Atmos Chem Phys. 2023 Sep 6;23(17):9911-9961. doi: 10.5194/acp-23-9911-2023. Atmos Chem Phys. 2023. PMID: 37990693
Competing Domino Knoevenagel-Cyclization Sequences with N-Arylcinnamylamines.
Kajtár M, Király SB, Bényei A, Kiss-Szikszai A, Kónya-Ábrahám A, Zhang N, Horváth LB, Bősze S, Li D, Kotschy A, Paczal A, Kurtán T. Kajtár M, et al. Among authors: horvath lb. J Org Chem. 2024 May 1. doi: 10.1021/acs.joc.4c00299. Online ahead of print. J Org Chem. 2024. PMID: 38691817
[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial.
Emmett L, Subramaniam S, Crumbaker M, Nguyen A, Joshua AM, Weickhardt A, Lee ST, Ng S, Francis RJ, Goh JC, Pattison DA, Tan TH, Kirkwood ID, Gedye C, Rutherford NK, Sandhu S, Kumar AR, Pook D, Ramdave S, Nadebaum DP, Voskoboynik M, Redfern AD, Macdonald W, Krieger L, Schembri G, Chua W, Lin P, Horvath L, Bastick P, Butler P, Zhang AY, Yip S, Thomas H, Langford A, Hofman MS, McJannett M, Martin AJ, Stockler MR, Davis ID; ENZA-p Trial Investigators and the Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Emmett L, et al. Among authors: horvath l. Lancet Oncol. 2024 Apr 12:S1470-2045(24)00135-9. doi: 10.1016/S1470-2045(24)00135-9. Online ahead of print. Lancet Oncol. 2024. PMID: 38621400
Clinical validation of circulating GDF15/MIC-1 as a marker of response to docetaxel and survival in men with metastatic castration-resistant prostate cancer.
Mahon KL, Sutherland SI, Lin HM, Stockler MR, Gurney H, Mallesara G, Briscoe K, Marx G, Higano CS, de Bono JS, Chi KN, Clark G, Breit SN, Brown DA, Horvath LG. Mahon KL, et al. Among authors: horvath lg. Prostate. 2024 Jun;84(8):747-755. doi: 10.1002/pros.24691. Epub 2024 Mar 27. Prostate. 2024. PMID: 38544345
703 results